Skip to main content

Rhenman & Partners Asset Management AB

Position in VKTX — Viking Therapeutics, Inc.

CIK 1599882 Stockholm, V7

Position in VKTX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$4,993,280
-$213,120 QoQ
Shares Held
128,000
-20.0% QoQ
Ownership
0.110%
of shares outstanding
% of Portfolio
0.47%
of 13F equity value
Holder Rank
#68
of 435 holders
Holding Since
Mar 2020
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VKTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Rhenman & Partners Asset Management AB holds $335,352,902 across 39 Biotechnology names. VKTX ranks #27 (1.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in VKTX

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,993,280 128,000
2026-03-31 $5,206,400 160,000
2025-12-31 $2,919,940 83,000
2025-09-30 $5,684,048 216,288
2025-06-30 $2,252,500 85,000
2025-03-31 $2,415,000 100,000
2024-12-31 $3,621,600 90,000
2024-09-30 $6,489,275 102,500
2024-06-30 $6,096,150 115,000
2024-03-31 $11,890,000 145,000
2023-12-31 $3,349,800 180,000
2023-09-30 $1,992,600 180,000
2023-06-30 $2,917,800 180,000
2023-03-31 $2,997,000 180,000
2020-03-31 $936,000 200,000